Cargando…
Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, has triggered a global pandemic that has prompted severe public health concerns. Researchers worldwide are continuously trying to find options that could be effective against COVID-19. The main focus of r...
Autores principales: | Anjani, Kumar, Sumit, Rathi, Brijesh, Poonam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890797/ https://www.ncbi.nlm.nih.gov/pubmed/36756584 http://dx.doi.org/10.1039/d2ra06834f |
Ejemplares similares
-
An updated review of fatty acid residue-tethered heterocyclic compounds: synthetic strategies and biological significance
por: Majrashi, Taghreed A., et al.
Publicado: (2023) -
Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022) -
Recent updates on the bioactive compounds of the marine-derived genus Aspergillus
por: Orfali, Raha, et al.
Publicado: (2021) -
In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-M(Pro) inhibitors
por: Aljuhani, Ateyatallah, et al.
Publicado: (2022) -
Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies
por: Kumar, Sumit, et al.
Publicado: (2021)